Literature DB >> 6896527

Modulation of the vasoconstrictor response to adrenergic stimulation by nucleosides and nucleotides.

P Lukacsko, A Blumberg.   

Abstract

The ability of nucleosides and nucleotides to modulate adrenergic neuromuscular transmission was examined in the isolated, perfused rat mesentery. The nucleosides adenosine and cytidine and the stable nucleotide of ATP, beta, gamma-methylene ATP (APPCP), and GTP depressed in a concentration-dependent manner the vasoconstrictor response to nerve stimulation (NS). APPCP and cytidine required concentrations less than those of adenosine or GTP to cause inhibition of the constriction to NS. Guanosine had no apparent effect on the constriction to NS, whereas cytidine 5'-triphosphate enhanced this response. In contrast to the inhibitory effect of several nucleotides and nucleosides on the response to NS, only adenosine depressed the vasoconstriction to exogenous norepinephrine (NE). APPCP, GTP, cytidine 5'-triphosphate and guanosine were essentially equipotent in potentiating the vasoconstriction to NE; cytidine had no apparent effect. The ability of these agents to enhance vasoconstriction is not specific for alpha adrenergic receptor-mediated effects inasmuch as APPCP also potentiated the vasopressor response to KCl. Theophylline abolished the depressant effects of adenosine, cytidine, APPCP and GTP on the vasoconstriction to NS and the ability of adenosine to inhibit the constrictor response to NE. Theophylline did not inhibit the ability of APPCP to potentiate the vasoconstriction to NE. These results indicate that the nucleosides adenosine, guanosine and cytidine and the nucleotides APPCP and GTP act prejunctionally, possibly at a common receptor, to inhibit the neuronal release of NE. In addition, the data suggest the existence of two postjunctional sites, one that is inhibitory and selective for adenosine and another that enhances vasoconstrictor responses and is activated by nucleotides and guanosine.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6896527

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  6 in total

1.  Characterization of prejunctional purinoceptors on adrenergic nerves of the rat caudal artery.

Authors:  K Shinozuka; R A Bjur; D P Westfall
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1988-09       Impact factor: 3.000

2.  Adenosine-induced secretion in the canine trachea: modification by methylxanthines and adenosine derivatives.

Authors:  H G Johnson; M L McNee
Journal:  Br J Pharmacol       Date:  1985-09       Impact factor: 8.739

3.  Prejunctional modulation of noradrenaline release in mouse and rat vas deferens: contribution of P1- and P2-purinoceptors.

Authors:  K Kurz; I von Kügelgen; K Starke
Journal:  Br J Pharmacol       Date:  1993-12       Impact factor: 8.739

4.  Evidence for P2-purinoceptor-mediated inhibition of noradrenaline release in rat brain cortex.

Authors:  I von Kügelgen; L Späth; K Starke
Journal:  Br J Pharmacol       Date:  1994-11       Impact factor: 8.739

5.  Contribution of P1-(A2b subtype) and P2-purinoceptors to the control of vascular tone in the rat isolated mesenteric arterial bed.

Authors:  A Rubino; V Ralevic; G Burnstock
Journal:  Br J Pharmacol       Date:  1995-06       Impact factor: 8.739

6.  Stable adenine nucleotides inhibit [3H]-noradrenaline release in rabbit brain cortex slices by direct action at presynaptic adenosine A1-receptors.

Authors:  I von Kügelgen; L Späth; K Starke
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1992-08       Impact factor: 3.000

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.